INS and Alzheimer disease: In addition to the direct roles of insulin and IDE, accumulating evidence shows that under diabetic conditions, impairments in certain insulin receptor- (IR-) responsive cellular signaling pathways might also mechanistically promote AD-related neuropathology and cognitive deterioration [13–18].